Investigating the
Promise of Camlipixant

Camlipixant (BLU-5937) is currently undergoing clinical testing. All investigational products must be tested in clinical trials before they can be approved by the U.S. Food and Drug Administration and similar regulatory authorities worldwide.

Expanded Access Policy